July 20, 2018 — Boston Scientific Corp.
Embolic Protection Devices
This channel includes news and new technology innovations for embolic protection systems to prevent emboli from flowing down stream (distally) in arteries due to interventional or TAVR procedures.
-
-
September 18, 2017 – Claret Medical announced publication of a new study in the...
-
June 5, 2017 – The U.S. Food and Drug Administration (FDA) granted market clearance for the Claret Medical Sentinel Cerebral Protection System (CPS), via de novo classification, enabling U.S.
-
Studies have shown transcatheter aortic valve replacement (TAVR) has an increased risk of stroke and cerebral damage due to emboli released during the procedure.
News | Embolic Protection Devices | August 03, 2018
August 3, 2018 — Boston Scientific Corp. announced it has recently closed its...
Claret's FDA-cleared Sentinel Cerebral Embolic Protection System for TAVR will expand Boston Scientific's structural heart portfolio. It collects emboli knocked loose that would otherwise lodge in the brain and potentially cause a stroke.
News | Embolic Protection Devices | July 20, 2018
July 20, 2018 — Boston Scientific Corp. today has signed an agreement to acquire Claret Medical Inc., which has...
The Emboliner Embolic Protection Catheter is designed to capture debris released from the valve and vessel walls during transcatheter aortic valve replacement (TAVR) procedures. It allows for the passage of other catheters during TAVR procedures.
News | Embolic Protection Devices | June 07, 2018
June 7, 2018 — The first clinical cases have been completed where the Emboliner...
News | Embolic Protection Devices | May 08, 2018
May 8, 2018 — One-year results from the Sentinel Cerebral Protection System show it can reduce the incidence of...
News | Embolic Protection Devices | April 20, 2018
April 20, 2018 — Emerging medical device company Emboline Inc. announced it has completed a Series B funding round...
News | Embolic Protection Devices | February 19, 2018
February 19, 2018 — Claret Medical announced that since U.S. Food and Drug Administration (FDA) clearance in June...
The Boston Scientific FilterWire EZ embolic protection system.
News | Embolic Protection Devices | October 31, 2017
October 31, 2017 — The VAMPIRE 3 study evaluated if the selective use of distal filter protection might decrease the...
News | Embolic Protection Devices | October 23, 2017
October 23, 2017 — Claret Medical announced that it has closed on a Series C financing of $14.5 million led by...
News | Embolic Protection Devices | September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
News | Embolic Protection Devices | September 07, 2017
September 7, 2017 — Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection...
News | Embolic Protection Devices | August 23, 2017
August 23, 2017 — PinnacleHealth is the first hospital in Pennsylvania and one of the first 10 in the country to...
Feature | Heart Valve Technology | June 09, 2017
June 5, 2017 – The U.S. Food and Drug Administration (FDA) granted market clearance for the Claret Medical Sentinel ...
News | Peripheral Artery Disease (PAD) | May 17, 2017
May 17, 2017 — Contego Medical LLC announced recently that it has received CE Marking of its Vanguard IEP Peripheral...
News | Embolic Protection Devices | April 11, 2017
April 11, 2017 — Through a new clinical trial, patients at Harrisburg, Pa.-based PinnacleHealth have access to an...
The CardioGard embolic protection system for surgical aortic valve replacement.
Feature | Embolic Protection Devices | March 22, 2017
March 22, 2017 — Two U.S. Food and Drug Administration (FDA)-cleared embolic protection systems designed to remove...
